Mentions (24h)
Mentions (7d)
Sentiment (avg / median)
Sentiment Mix
Coverage Z-Score (24h vs 90d)
Top Sources (7d)
Co-Topics (7d)
Mentions by Hour (Last 24h)
Tariffs and GLP-1s are keeping people from dining out. An analyst tries to find the positives.
There’s “little to no appetite” for restaurant stocks right now, BTIG says, but Wingstop and Chipotle represent “rare opportunities.”…
Market Watch · 2025-10-08 18:55:00
JM Smucker to spend over $120M on Hostess plant expansion
The Twinkies owner was acquired two years ago for $5.6 billion, but has since seen demand wane amid inflation and an uptick in the use of GLP-1 drugs.…
Construction Dive · 2025-10-06 14:13:00Eli Lilly to build $6.5 billion Texas manufacturing facility for obesity pill, other drugs
More production capacity for the obesity pill is crucial as Eli Lilly races to bring it to market and tries to maintain its dominance in the GLP-1 market.…
CNBC Business · 2025-09-23 17:00:27Pfizer just paid a lot of cash to catch up in the GLP race. Why its stock is higher
Pfizer is spending more than $7 billion to buy biotech Metsera to try to catch cup in the obesity drug market.…
CNBC Top Stories · 2025-09-22 19:39:05Lilly :Mounjaro Shows 2.2% A1C Drop In Phase 3 Trial For Children & Adolescents With Type 2 Diabetes
(RTTNews) - Eli Lilly and Co. (LLY) announced detailed results from SURPASS-PEDS, the first Phase 3 trial evaluating the safety and efficacy of Mounjaro (tirzepatide)—a GIP/GLP-1 dual receptor agonist—in children and ad…
NASDAQ Markets · 2025-09-18 01:36:16
Protein snacks are getting more popular thanks to weight-loss drugs, says General Mills
While people on GLP-1 drugs are reducing their overall calories, the packaged-foods producer says they have a growing hunger for protein as they lose muscle mass.…
Market Watch · 2025-09-17 20:35:00
GLP-1 drugs could save millions of lives — and spark a pension crisis
GLP-1 drugs are so powerful that, in 20 years, they can save millions from premature death, a leading insurance company says.…
Market Watch · 2025-09-17 14:05:00
FDA Tightens Control Over Obesity Drug Ingredient Imports Amid Safety Concerns
The U.S. Food and Drug Administration is tightening oversight of imports of GLP-1 drug ingredients, used for weight loss and diabetes, amid concerns that many of the items may be adulterated and pose a safety risk. The move comes as the FDA…
Daily Wire · 2025-09-05 13:15:12GLP Crosses Below Key Moving Average Level
In trading on Wednesday, shares of Global Partners LP (Symbol: GLP) crossed below their 200 day moving average of $52.26, changing hands as low as $52.00 per share. Global Partners LP shares are currently trading off about 0.4% on…
NASDAQ Stocks · 2025-09-03 11:18:08Small GLP-1 doses are latest longevity ‘craze.’ There’s scant evidence they work.
Internet companies are helping stoke enthusiasm for “microdosing” weight-loss drugs for wellness, mood and joint pain.…
The Washington Post · 2025-09-03 10:00:42
